Prometheus Biosciences, Inc., (RXDX) Social Stream
PROMETHEUS BIOSCIENCES INC (RXDX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PROMETHEUS BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 3 | $40 | $34 | $36.333 | $199.92 | -81.83% |
| 2021-11-15 | 5 | $45 | $35 | $40.75 | $199.92 | -79.62% |
| 2021-12-08 | 5 | $50 | $40 | $44.8 | $199.92 | -77.59% |
| 2022-01-13 | 7 | $50 | $40 | $45 | $199.92 | -77.49% |
| 2022-02-11 | 7 | $62 | $40 | $47.428 | $199.92 | -76.28% |
| 2022-03-10 | 7 | $62 | $40 | $48.571 | $199.92 | -75.7% |
| 2022-05-12 | 6 | $62 | $42 | $50 | $199.92 | -74.99% |
| 2022-05-17 | 8 | $62 | $42 | $50 | $199.92 | -74.99% |
| 2022-06-10 | 8 | $62 | $42 | $50.375 | $199.92 | -74.8% |
| 2022-07-26 | 9 | $62 | $42 | $50.444 | $199.92 | -74.77% |
| 2022-08-11 | 9 | $62 | $42 | $50.888 | $199.92 | -74.55% |
| 2022-08-12 | 9 | $62 | $42 | $53.777 | $199.92 | -73.1% |
| 2022-08-29 | 9 | $71 | $50 | $58.555 | $199.92 | -70.71% |
| 2022-10-03 | 9 | $74 | $50 | $59.888 | $199.92 | -70.04% |
| 2022-10-20 | 9 | $74 | $50 | $62.111 | $199.92 | -68.93% |
| 2022-11-01 | 9 | $74 | $51 | $62.666 | $199.92 | -68.65% |
| 2022-11-10 | 9 | $74 | $51 | $62.555 | $199.92 | -68.71% |
| 2022-12-08 | 9 | $185 | $51 | $117.1 | $199.92 | -41.43% |
| 2022-12-11 | 9 | $185 | $51 | $127.1 | $199.92 | -36.42% |
| 2022-12-16 | 9 | $185 | $51 | $137.1 | $199.92 | -31.42% |
| 2023-02-08 | 9 | $185 | $111 | $146.4 | $199.92 | -26.77% |
| 2023-03-01 | 9 | $185 | $111 | $149.9 | $199.92 | -25.02% |
| 2023-03-05 | 10 | $185 | $111 | $154.8 | $199.92 | -22.57% |
| 2023-03-06 | 10 | $225 | $111 | $158.8 | $199.92 | -20.57% |
| 2023-04-17 | 9 | $200 | $111 | $160.8 | $199.92 | -19.57% |
| 2023-04-18 | 9 | $200 | $144 | $179.5 | $199.92 | -10.21% |
| 2023-05-17 | 9 | $200 | $144 | $187.222 | $199.92 | -6.35% |
The Trend in the Analyst Price Target
Over the past 26 months, RXDX's average price target has gone up $154.97.
RXDX reports an average of 18.2% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-01 | 9 | 74 | 51 | 62.666 | 51.35 | 22.04% |
| 2022-12-16 | 9 | 185 | 51 | 137.100 | 108.76 | 26.06% |
| 2023-01-31 | 9 | 185 | 111 | 146.400 | 113.66 | 28.81% |
| 2023-03-06 | 10 | 225 | 111 | 158.800 | 122.55 | 29.58% |
| 2023-05-17 | 9 | 200 | 144 | 187.222 | 192.94 | -2.96% |
RXDX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 3 | 0 | 6 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
RXDX's average broker recommendation rating worsened by 1.22 over the prior 120 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RXDX has a greater upside potential (average analyst target price relative to current price) than 54.49% of all US stocks.
- In terms of how PROMETHEUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 2826.37% of that group.
- In terms of how PROMETHEUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -934.17% of that group.
- In terms of how PROMETHEUS BIOSCIENCES INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 1907.05% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROMETHEUS BIOSCIENCES INC are VERV, ATAI, and VIR.
View All Top Stocks by Price Target
Make investment decisions regarding RXDX using the data that counts. Try POWR Ratings for free.